This protocol will involve collection of blood samples from patients with a diagnosis of pancreatic adenocarcinoma for evaluation of circulating biomarkers.
Study Type
OBSERVATIONAL
Enrollment
30
4 tbsp of blood in a 1-week period, occurring no more frequently than 4 times in an 8-week period
Abramson Cancer Center at University of Pennsylvania
Philadelphia, Pennsylvania, United States
RECRUITINGTo create a comprehensive system to collect, catalogue and store blood specimens from subjects with pancreatic cancer for future research use.
Time frame: Through study completion, an average of 1 year
To create a computerized clinical data set from subjects with pancreatic cancer that contains information related to the subject's general health, disease status, treatments, and response.
Time frame: Through study completion, an average of 1 year
To integrate the data and specimens to permit the most informative clinical-biologic research platform.
Time frame: Through study completion, an average of 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.